As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At RAPT Therapeutics, a filing with the SEC revealed that on Wednesday, Director Wendye Robbins bought 2,600 shares of RAPT, for a cost of $26.01 each, for a total investment of $67,632. So far Robbins is in the green, up about 14.7% on their purchase based on today's trading high of $29.83. RAPT Therapeutics is trading up about 5% on the day Thursday. Before this latest buy, Robbins made one other purchase in the past twelve months, buying $19,200 shares for a cost of $12.00 each.
And at Ampco-Pittsburgh, there was insider buying on Monday, by Director Carl H. Pforzheimer II who purchased 20,000 shares at a cost of $2.85 each, for a trade totaling $57,020. Ampco-Pittsburgh is trading up about 4.1% on the day Thursday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.